Skip to main content
Dabur India Ltd. logo

Dabur India Ltd. — Investor Relations & Filings

Ticker · DABUR ISIN · INE016A01026 LEI · 335800MJPUA2E1FSFL38 BSE.NS Manufacturing
Open in API
Filings indexed 2,055 across all filing types
Latest filing 2020-05-27 Regulatory Filings
Country IN India
Listing BSE.NS DABUR

About Dabur India Ltd.

https://www.dabur.com

Dabur India Ltd. specializes in Ayurvedic and natural healthcare solutions, managing a diverse portfolio across health supplements, oral care, hair care, skin care, home care, and food and beverages. Established in 1884, the organization integrates traditional Ayurvedic wisdom with modern scientific research to develop standardized herbal products. Key brands include Dabur Chyawanprash, Dabur Honey, Real fruit juices, Vatika, and Dabur Red Paste. The company maintains a robust research and development framework to support its focus on natural ingredients and holistic health. Its operations serve a wide demographic across international markets, emphasizing the synergy between nature and science through an extensive distribution network and a commitment to quality-driven consumer products.

Recent filings

Filing Released Lang Actions
Press release on Dabur India Limited Q4 Financial Results is being submitted
Regulatory Filings Classification · 90% confidence The document text is extremely short (353 characters) and contains only placeholders for omitted pictures without any substantive text or financial data. There is no indication of report content, financial statements, or detailed information. Given the lack of content and the presence of only images, this document does not fit any detailed report category. It is most consistent with a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2020-05-27 English
Dabur India Ltd has informed BSE that the Board of Directors of the Company in its meeting held on May 27, 2020, inter alia, has recommended Final Dividend of Rs. 1.60 per equity share ....
Audit Report / Information Classification · 95% confidence The document is an Independent Auditor's Report on Consolidated Annual Financial Results for the year ended March 31, 2020, submitted pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It includes detailed auditor opinions, basis for opinion, management responsibilities, and auditor responsibilities, all typical of an audit report. The document also mentions the audited financial and segment-wise results for the quarter and year ended March 31, 2020, along with the auditor's report and statement of assets and liabilities. This is not merely an announcement or a brief summary but contains substantive audit content and financial results. Therefore, it fits the category of an Audit Report / Information (AR) rather than a full Annual Report (10-K) or an Earnings Release (ER). The document length (15,000 characters) and detailed content confirm it is a full audit report rather than a short announcement or certification. FY 2020
2020-05-27 English
Investor Presentation
Interim / Quarterly Report Classification · 95% confidence The document is a detailed presentation titled 'Q4 FY20 – Results Presentation' dated 27th May 2020, containing extensive financial performance data for FY20 and Q4 FY20, including revenue, profit, and segment growth figures. It also discusses the impact of Covid-19 on financials, operational strategies, and outlook for Q1 FY21. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The content includes consolidated profit and loss statements and detailed business analysis, which are characteristic of an Interim / Quarterly Report. There is no indication that this is merely an announcement or a press release without substantive financial data. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). FY 2020
2020-05-27 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated May 27, 2020, issued by Dabur India Ltd. It contains detailed financial results for the quarter and full year ended March 31, 2020, including revenue, net profit, and business performance commentary. It also discusses the impact of COVID-19 on the business, future strategy, and dividend declaration. The document is not a full annual report but an initial announcement of quarterly and annual financial results with key highlights. It is not a transcript, audit report, or regulatory filing. The presence of financial results and commentary in a press release format aligns with an Earnings Release (ER). The document length (8353 characters) and content support this classification rather than a full Annual Report (10-K) or Interim Report (IR).
2020-05-27 English
Updates
Regulatory Filings Classification · 95% confidence The document is a submission under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, specifically disclosing the material impact of the COVID-19 pandemic on the company. It references a SEBI circular and provides detailed information about the pandemic's impact on operations, liquidity, and financial position. The document is addressed to stock exchanges and is a regulatory disclosure rather than a full financial report. It does not contain comprehensive financial statements or detailed financial analysis typical of Annual Reports (10-K) or Interim Reports (IR). It is also not a certification or attestation letter, nor is it a brief announcement or a proxy solicitation. Given the nature of the disclosure and the regulatory context, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-27 English
Submission of information under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 - in the context of pandemic of Corona virus (Covid-19)
Management Reports Classification · 95% confidence The document discusses the impact of the COVID-19 pandemic on the company's operations, including financial impacts on revenue and profit, operational status of factories, liquidity position, ability to service debt, supply chain disruptions, and demand for products. It provides detailed operational and financial information related to a specific period (Q4FY20 and Q1FY21). The content is focused on management's assessment and explanation of business conditions and outlook due to the pandemic, which aligns with a Management Discussion and Analysis (MDA) report. The document length is 7932 characters, which is sufficient for a substantive report rather than a brief announcement. There is no indication that this is a full annual or interim financial report, nor is it a regulatory filing or certification. Therefore, the best classification is Management Reports (MDA).
2020-05-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.